loperamide hydrochloride 2 MG / simethicone 125 MG Oral Tablet [Imodium Multi-Symptom Relief]
RxNorm concept 1426827, branded drug (sbd). Prescribable name: Imodium Multi-Symptom Relief 2 MG / 125 MG Oral Tablet.
- RxCUI
- 1426827
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1426827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Imodium Multi-Symptom Relief (loperamide HCl 2 MG / simethicone 125 MG) Oral Tablet
Related concepts
- simethicone 125 MG (SCDC, consists of)
- loperamide hydrochloride 2 MG (SCDC, consists of)
- loperamide hydrochloride 2 MG / simethicone 125 MG [Imodium Multi-Symptom Relief] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Imodium Multi-Symptom Relief (BN, has ingredient)
- loperamide hydrochloride 2 MG / simethicone 125 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00045021212
- 00045021218
- 50580033806
- 50580033807
- 50580033812
- 50580033818
- 50580033830
- 50580033842
- 50580033850
- 50580033851
- 50580033852
- 50580033860
- 50580033861
- 50580033864
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1426827 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1426827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1426827. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.